Germany· DE-A57-b88378f6a79511ca
Vinorelbin Phares
A vinorelbine product containing vinorelbine tartrate, registered in Germany by Pharma Resources Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Vinorelbine is registered in 18 of 19 countries.
Countries holding a registration under ATC L01CA04 (vinorelbine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Vinorelbine · ATC L01CA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vinorelbine costs, country by country.
Normalised to the WHO defined daily dose (18 mg), the median price runs from $23.93 in France to $49.84 in Switzerland — a ×2.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vinorelbine · price per daily dose (18 mg)
USD · FX 28 Sept 2026
- CH Switzerland$49.84
- IT Italy$38.71
- FR France$23.93
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Vinorelbine Tartrate
- Manufacturer
- Pharma Resources Gmbh
- Country
- Germany (DE)
- ATC code
- L01CA04
- ATC class
- Vinorelbine
- Defined daily dose
- 18 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
536 interactions on record for vinorelbine.
Graded by severity as the source publishes them — 60 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vinorelbine · interactions on record
536 records
- 60 severe
- 307 moderate
- 17 minor
- 152 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vinorelbine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNAVELBINEPIERRE FABRE MEDICAMENT, Lavaur
- FinlandNavelbineOrifarm Oy
- United KingdomNavelbine 10mg/1ml concentrate for solution for infusion vialsPierre Fabre Ltd
- SwedenNavelbine 20 mg Kapsel, mjukPierre Fabre Medicament
- SpainNAVELBINE 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONPierre Fabre Iberica S.A.
- PolandNavelbinePierre Fabre Medicament
- FranceNAVELBINE 10 mg/1 ml, solution injectable en flaconPIERRE FABRE MEDICAMENT
- SwitzerlandNavelbine 20 mg, WeichkapselnPierre Fabre Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Eberelbin, Navelbine
- Belgium · Vinorelbin Eugia, Vinorelbine Accord Healthcare
- Bulgaria · Винорелбин "ебеве"
- Cyprus · Navirel, Vinorelbine Accord
- Czechia · Navelbine, Navelbine Oral
- Denmark · Navelbine, Navirel
- Estonia · Navelbine, Vinorelbin Ebewe
- Spain · Navelbine, Vinorelbina Accord
- Finland · Navelbine, Vinorelbin Ebewe
- France · Navelbine, Vinorelbine
- United Kingdom (Northern Ireland) · Navelbine, Vinorelbine
- Greece · Navelbine, Zaolin
- Croatia · Vinorelsin
- Hungary · Vinorelbin Sandoz
- Ireland · Navelbine, Vinorelbine Accord
- Iceland · Navelbine, Navirel
- Italy · Navelbine, Vinorelbina Accord
- Lithuania · Navelbine, Vinorelbin Ebewe
- Luxembourg · Vinorelbin Ab, Vinorelbin Eugia
- Latvia · Vinorelbine Accord
- Malta · Vinorelbine Lotus, Vinorelbine Medac
- Netherlands · Navelbine, Navirel
- Norway · Navelbine, Navirel
- Poland · Navelbine, Navirel
- Portugal · Navelbine, Vinorrelbina
- Romania · Navelbine, Vinorelbin Teva
- Sweden · Navelbine, Navirel
- Slovenia · Vinorelbin Accord, Vinorelbin Sandoz
- Slovakia · Navelbine, Navelbine Oral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5106c490-7477-42e2-8038-fe025b5ed22d GET /v1/drugs/5106c490-7477-42e2-8038-fe025b5ed22d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Vinorelbine Tartrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about vinorelbine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.